Clorox (CLX) executive compensation, 2026 proxy

Linda Rendle, Chair and Chief Executive Officer (CEO), was paid $14M in fiscal year 2026, up 5% from $13.3M the year before. The CEO-to-median-employee pay ratio was 168:1, on median employee pay of $83,267.

Filed
October 7, 2026
Pay year
fiscal year 2026
Named executives
5
CEO total pay
$14M+5% vs prior year
CEO to median employee
168:1median $83,267
CEO pay in equity
76%$10.7M in awards
Short-term incentive multiplier
54%Fiscal 2026 company multiplier
Performance share payout
69%Fiscal 2024–2026 performance period
Maximum CEO PSU value
$12,839,824Fiscal 2026 grant
CEO stock awards
$10,699,895Fiscal 2026 grant-date value
CEO perquisites
$298,813Included aircraft and security

How Rendle was paid

$14M in total for fiscal year 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Stock awards76%Non-equity incentive9%All other compensation5%

Named executive officers

ExecutiveTotal
Linda RendleChair and Chief Executive Officer (CEO)$14,000,460
Luc BelletEVP and Chief Financial Officer (CFO)$7,666,614
Chris HyderEVP and Chief Operating Officer$7,571,244
Kirsten MarrinerEVP and Chief Administrative Officer$6,243,658
Angela HiltEVP and Chief Legal & External Affairs Officer and Corporate Secretary$6,029,604

What changed and why

  • 54%54% company multiplier reduced fiscal 2026 short-term incentive payouts below target after ERP-related operational challenges and weaker business performance.
  • 69%69% payout on performance share units reflected economic profit growth across fiscal years 2024 through 2026.
  • $10.7M$10.7 million in stock awards represented the largest component of Linda Rendle’s $14.0 million fiscal 2026 compensation.
  • $299K$298,813 in company-paid perquisites for Rendle included charter aircraft use and personal security.
  • May 2026 CEO succession planning began after Rendle announced her decision to step down for health reasons.
  • GOJO Industries acquisition expanded Clorox’s health and hygiene platform and business-to-business presence.

Other Clorox proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.